Twitter Facebook LinkedIn YouTube

LED Medical Diagnostics (TSXV: LMD) Appoints Lamar Roberts as President of its subsidiary LED Dental Ltd.

Video Platform Video Management Video Solutions Video Player

LED Medical Diagnostics (TSXV: LMD) Appoints Lamar Roberts as President of its subsidiary LED Dental Ltd. LED Medical develops LED-based visualization technologies for the medical industries.

Additional Information:

Company: LED Medical Diagnostics
Stock Symbol: TSXV: LMD
Date Published: Feb 28, 2014
Transcript: Available

Video Transcript:

I’m Megan Edwards for

Investment firm Mackie Research has initiated coverage on Atrium Mortgage Investment Corporation, which trades on the Toronto Stock Exchange, under the symbol “AI”. Analyst Adam Seanor gives the company a buy rating, and a 12 month target price of $12.00, a premium of 18% to the $10.13 price the day the report was issued.

Headquartered in Toronto, Atrium is non-bank lender, which provides creative financing solutions while focusing on loans that do not fit the rigid lending policies of major financial institutions.

Although specializing in non-conforming mortgages, actual realized losses of only $131,000 over the 11 years since inception indicate the high quality of the portfolio and management’s expertise at managing the portfolio.

Atrium pays a regular monthly distribution of $0.067 per month in addition to an annual 13th dividend of $0.02 for 2012, giving investors an annual yield of approximately 7.5%

As a MIC, Atrium must pay out 100% of earnings to investors each year to retain its tax-free status.

Analyst Adam Seanor stated, “We forecast earnings per share of $0.86 and $0.90 for 2013 and 2014, respectively. We forecast a $0.06 per share special dividend to be declared for F2013. “ (Megan – say as “for the full year 2013”)

Following the release of the 2nd quarter results, President & CEO Robert Goodall stated, “We have continued to actively manage our risk profile by targeting first mortgages in the particular real estate sectors that we feel are safest at this stage in the real estate cycle. The pipeline of business in our 3 offices is excellent, with over $20 million of approved loans ready to be funded.”

The shares are currently trading at $10.19, below Mackie Research’s target price of $12.00 and with 21.1 million shares outstanding the company is capitalized at $215 million.

For more information, please visit the company’s website or contact Robert Goodall, President & CEO at 416-607-4200 or email

For more information about Mackie Research or to obtain the report on Atrium, contact your nearest Mackie Research office. Their branches are listed on their website at

I’m Megan Edwards for
For more video news, and to view our disclaimer, be sure to visit our website
This video is for information purposes only and it is not a recommendation to buy or sell any securities.